Clinical Trials Browser

Has results × Carcinoma, Hepatocellular × CTLA-4 Antigen × Clear all

NCT03222076 2023-07-10

Nivolumab With or Without Ipilimumab in Treating Patients With Resectable Liver Cancer

Phase 2 Completed

30 enrolled 9 charts

Gastrointestinal

Carcinoma, Hepatocellular